Upvote Story 4

Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock

Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock

Temporary circulatory support (TCS) have become the cornerstone of the management of patients with cardiogenic shock, although the evidence supporting their efficacy is limited.

VA-ECMO is considered the first-line option, with a growing number of accepted and emerging indications.

Randomized clinical trials are now needed to determine the place VA-ECMO in cardiogenic shock treatment strategies.

VA-ECMO is utilized as a bridge to “decision” that includes weaning after cardiac function recovery, transplantation, long-term mechanical circulatory support, and withdrawal in case of futility.

VA-ECMO is considered the first-line TCS as it allows rapid improvement in oxygenation, is less expensive, and is also suitable for patients with biventricular failure.

CriticalCare.news
November 7, 2019

Leave Your Comment